Sponsored Links


Other Topics
Sponsored Links



Quote of the Day

"Many politicians are in the habit of laying it down as a self-evident proposition that no people ought to be free till they are fit to use their freedom. The maxim is worthy of the fool in the old story who resolved not to go into the water till he had learned to swim."

Thomas B. Macaulay

FEATURED
HEALTH
PRODUCTS
 
Guide To Healthier Eating And Weight
 
The Ultimate Collection Of Health Ebooks
 
A Healthy Back In Ten Minutes A Day
 
Complete Guide To Healthy Eating
 
Natural Health Remedies To Help Stress
 




 


Google


Warning: fopen(stopka/index.php) [function.fopen]: failed to open stream: No such file or directory in /stopka.php on line 117

Warning: fopen(stopka/6655d922aa2c1bbb44b556c10262be35.txt) [function.fopen]: failed to open stream: No such file or directory in /stopka.php on line 117


 
Featured Breast Cancer Articles

A Knife in the Back
Is surgery the best approach to chronic back pain?. Surgeons have often touted procedures that ultimately proved to be disappointing. In the nineteen-fifties, many patients with angina and coronary artery disease had an operation that involved tying off ...

Moving Through Menopause
It's a rite of passage that few women look forward to--menopause. The term refers to both the cessation of one's menstrual period, and to the time of transition accompanying this event. While many women look forward to the end of feminine hygiene ...

Your Health and Your Weight
Healthy Living Through The Ages! Like a good friend, a good attitude towards fitness andnutrition doesn't abandon us as we age. It matures right along with us, evolving as our lives change. That means we don't have to give up the activities or the foods ...





Malaysia And Breast Cancer
 
Breast cancer is the most common cancer among Malaysian women from all ethnicities and it is also the most common cause of cancer death among

women in Malaysia. The disease accounts for 30.4% of newly diagnosed cancer cases in Malaysian women. The incidence continues to rise as confirmed by the latest report of the Malaysian National Cancer Registry (Lim, Halimah, & Lim, 2003). Breast cancer incidence for 2002 is 4,337, compared to 3,825 for the year 2000. The actual number of women infected by the disease could be higher than the official figures as many women fail to seek treatment for various reasons.

In many developed nations the disease is prevalent among older women, but in Malaysia, the first and latest survey reveals that 52.3 percent of the cases of breast cancer involve women below 50 years of age. Over one third of the cases are in the pre-menopausal group. The disease strikes at the time when most working women are still raising children and establishing themselves in a career. In addition, the type of cancers that are found in this age group are often more difficult to treat.

Although, official rates of breast cancer mortality are not known, the number of deaths reported by a study released in the year 2001 is cause for alarm. According to the report, in the year 2000 deaths from the disease totaled 1,707; that is, close to 45 % of the cases result in death. The actual figure may be higher, owing to the underreporting of cases and the difficulties in obtaining accurate statistics from some geographically remote places. Unconfirmed reports suggest that although Malay women have the lowest incidence rates of breast cancer among the three major ethnic groups (incidence is reportedly highest among the Chinese, followed by the Indian), they have the highest mortality rates.

The Malaysian Medical Association asserts that women who were less likely to undergo breast examination are at a higher risk of late detection of breast cancer. This scenario is reportedly more prevalent among women who have low or no formal education, come from rural areas, live in agricultural communities, and are from low-income families (Lim, 2003). Furthermore, unofficial reports also suggest that many of the women who have been diagnosed with breast cancer often fail to seek treatment or discontinue their treatment.At present, there is scant research being carried out to understand these phenomena in Malaysia. Moreover, there is no institutional set up that concentrates upon utilizing such knowledge, even if it is available. Such a set up is crucial in the development and dissemination of culturally, ethically and linguistically appropriate breast cancer educational materials to effectively change those behaviors and beliefs that impede accurate understanding about the disease and the treatment of the disease.

Excerpts from National Cancer Registry (2003)

a. The most common cancer among women
b. The most common cancer among females in all ethnic groups
c. The most common cancer among females from age 20 years
d. 4337 new cases diagnosed in 2002.
e. 52.3% of the new cases in 2002 were in women below 50 years old
f. Overall crude rate (CR) -number of cases first notified for a given population - 45.1 per 100,000
g. Age-standardize incidence (ASR) - for meaningful comparison
of 2 population that differ in their age structure - 52.8
h. A women in Malaysia had a 1 in 19 chance of getting the diseases (1:14 for Chinese, 1:15 for Indian, and 1 in 24 for Malay)

From a study in two breast clinic in Kuala Lumpur Taken from : Yip, C.H., & Abdullah, N.H. (2003) Spectrum of breast cancer in Malaysian Women: Overview. World Journal of Surgery 27, 921-923

a. Peak age group range 40-49 years
b. The mean tumor size at presentation 5.4 cm
c. 50-60% of the newly diagnose cases are at stage 3 and 4
d. The tumor were much larger in Malay ethnic group patients
e. The advance stage of breast cancer is observed to be the highest among the Malay ethnic group
f. Percentage of advance cases is thought to be higher in rural hospitals
g. There are 16 breast clinic for 23 mil. population ( way below recommendation of 1:16 mil)
h. Nation-wide breast screening program is yet to be established
i. Situation in East Malaysia is not yet known
j. Delays in seeking treatment and defaults in further treatment are commonly observed.




Breast Cancer News



ABC News

Want to lower breast cancer risk? Lose a little weight
Los Angeles Times
For postmenopausal women who are obese, breast cancer is more likely. That's because fat tissue seems to behave essentially as an organ of the endocrine system, pumping out the hormone estrogen. And estrogen is a driver of many common breast cancers.
Small weight loss effectively reduces sex hormones linked with breast cancerFox News
Moderate Weight Loss Can Decrease Breast Cancer RiskABC News
Dieting May Lower Hormone Levels Tied to Breast CancerPhiladelphia Inquirer
TIME -Times of India
all 40 news articles »

Galena Biopharma's Breast Cancer Vaccine Sprouts More Red Flags
TheStreet.com
By Adam Feuerstein 05/22/12 - 02:23 PM EDT LAKE OSWEGO, Oregon (TheStreet) -- More red flags have been found staked into Galena Biopharma's(GALE) breast cancer vaccine NeuVax. Updated, 60-month follow-up results from a Neuvax phase II study scheduled ...
Galena Biopharma With Near Term ASCO CatalystSeeking Alpha

all 2 news articles »

Plenty of options after breast cancer surgery
MiamiHerald.com
And is there anything that can be done for the other breast so that they can be similar in clothes or a bathing suit? Congratulations on being a breast cancer survivor! Breast cancer affects one in approximately eight women in America and because of ...

and more »

Tesetaxel Results as Initial Chemotherapy for Women With Recurrent Breast ...
MarketWatch (press release)
BERKELEY HEIGHTS, NJ, May 22, 2012 (GLOBE NEWSWIRE) -- Genta Incorporated (GNTA) today announced results from the Company's Phase 2 clinical trial using tesetaxel as initial, single-agent chemotherapy in women with advanced breast cancer.
Advanced breast cancer drug produces positive phase 2 resultsMedCity News
Shares of Genta Inc. (GNTA) Climb as Company announces Phase II ResultsTech24

all 7 news articles »

Roche Drugs To Be Key Focus At Upcoming US Cancer Meeting ASCO
Wall Street Journal
VX) newest breast cancer drug is expected to be displayed in the US next month at a high-profile medical meeting. Roche is planning to present additional data from key studies at the American Society of Clinical Oncology, or ASCO, annual meeting in ...

and more »